跳至主要内容
临床试验/NCT01606865
NCT01606865已完成不适用

Does Platelet Inhibition Predict Surgery Related Bleeding in Patients Undergoing Non-Cardiac Surgery During Dual Antiplatelet Therapy

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 207 人开始时间: 2010年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
207
试验地点
1
主要终点
increased risk of bleeding (according to TIMI definition)

研究概览

简要总结

The aim of the study is to evaluate if there is an association between platelet inhibition and surgery-related bleeding in patients undergoing non-cardiac surgery during dual antiplatelet therapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • intake of Clopidogrel, Prasugrel, or Ticagrelor within the last 7 days
  • spontaneous bleeding or impeding surgery (major vascular surgery, intraperitoneal or intrathoracic surgery, ENT-surgery, orthopedic or trauma surgery, prostatic surgery)

排除标准

  • concomitant medication with warfarin
  • renal insufficiency needing dialysis
  • concomitant therapy with GPIIB/IIIA Antagonists
  • expected duration of operation >30min

结局指标

主要结局

increased risk of bleeding (according to TIMI definition)

时间窗: 24hours postoperatively

次要结局

未报告次要终点

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Helfried Metzler, MD

Prof.

Medical University of Graz

研究点 (1)

Loading locations...

相似试验

Platelet Inhibition and Bleeding in Patients... | 临床试验